Literature DB >> 3410100

Tubal embryo transfer as a treatment for infertility due to male factor.

J P Balmaceda1, C Gastaldi, J Remohi, C Borrero, T Ord, R H Asch.   

Abstract

Transvaginal follicular aspiration (TVA) with ultrasonically guided needles allows the transfer of in vitro generated embryos to the fallopian tubes (TET), performing only one surgical procedure in the process. Up to now, this approach has been used to treat 16 couples with infertility due to severe male factor. Follicular development was induced with a combination of clomiphene citrate and human menopausal gonadotropin (hMG) or follicle-stimulating hormone and hMG. Follicles were aspirated by TVA 36 hours after an injection of human chorionic gonadotropin 10,000 IU intramuscularly. A total of 169 oocytes were recovered (10.5 +/- 6.9 X +/- SD) from the 16 patients. There was failure of fertilization in 6 cases. In the remaining 10, a TET was performed 44 to 50 hours after TVA, utilizing embryos at the pronuclear stage. Six pregnancies resulted from the 10 transfers. This technique combines the advantages of proof of fertilization with a more adequate tubal embryo development and entrance to the uterine cavity that may determine and increase chance of implantation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410100     DOI: 10.1016/s0015-0282(16)60136-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Assisted reproductive technologies do not alter mutation frequency or spectrum.

Authors:  Lee Caperton; Patricia Murphey; Yukiko Yamazaki; C Alex McMahan; Christi A Walter; Ryuzo Yanagimachi; John R McCarrey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

2.  Effect of the number and depth of embryos transferred and unilateral or bilateral transfer in tubal embryo transfer (TET).

Authors:  Y S Yang; S Melinda; H N Ho; J L Hwang; S U Chen; H R Lin; S C Huang; T Y Lee
Journal:  J Assist Reprod Genet       Date:  1992-12       Impact factor: 3.412

Review 3.  Critical reappraisal of the clinical effectiveness of different methods of assisted fertilization.

Authors:  G B Melis; F Strigini; V Mais; A M Paoletti; L Olivieri; D Antinori; S Guerriero; A de Ruggiero; F D Petacchi; P Fioretti
Journal:  J Endocrinol Invest       Date:  1990-03       Impact factor: 4.256

4.  A prospective study of echographic endometrial characteristics and pregnancy rates during hormonal replacement cycles.

Authors:  V Alam; L Bernardini; J Gonzales; R H Asch; J P Balmaceda
Journal:  J Assist Reprod Genet       Date:  1993-04       Impact factor: 3.412

5.  The role of gamete intrafallopian transfer (GIFT) and tubal embryo transfer (TET) in the treatment of patients with patent tubes associated with male infertility factor.

Authors:  R Seracchioli; A Maccolini; E Porcu; A Borini; M Cattoli; P Ciotti; F Violini; C Flamigni
Journal:  J Assist Reprod Genet       Date:  1993-05       Impact factor: 3.412

6.  Methodology of human embryo transfer following assisted reproduction.

Authors:  S Friedler; A Lewin; J G Schenker
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412

7.  Vaginal bleeding and early pregnancy outcome in an infertile population.

Authors:  Z N Dantas; A P Singh; P Karachalios; R H Asch; J P Balmaceda; S C Stone
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

8.  Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

Authors:  E Araujo; L Bernardini; J L Frederick; R H Asch; J P Balmaceda
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

Review 9.  In vitro fertilization in Japan - early days of in vitro fertilization and embryo transfer and future prospects for assisted reproductive technology.

Authors:  Masakuni Suzuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.